Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 53

1.

Aspirin and extended-release dipyridamole versus clopidogrel for recurrent stroke.

Sacco RL, Diener HC, Yusuf S, Cotton D, Ounpuu S, Lawton WA, Palesch Y, Martin RH, Albers GW, Bath P, Bornstein N, Chan BP, Chen ST, Cunha L, Dahlöf B, De Keyser J, Donnan GA, Estol C, Gorelick P, Gu V, Hermansson K, Hilbrich L, Kaste M, Lu C, Machnig T, Pais P, Roberts R, Skvortsova V, Teal P, Toni D, Vandermaelen C, Voigt T, Weber M, Yoon BW; PRoFESS Study Group.

N Engl J Med. 2008 Sep 18;359(12):1238-51. doi: 10.1056/NEJMoa0805002. Epub 2008 Aug 27.

2.

Clinical effectiveness and cost-effectiveness of clopidogrel and modified-release dipyridamole in the secondary prevention of occlusive vascular events: a systematic review and economic evaluation.

Jones L, Griffin S, Palmer S, Main C, Orton V, Sculpher M, Sudlow C, Henderson R, Hawkins N, Riemsma R.

Health Technol Assess. 2004 Oct;8(38):iii-iv, 1-196. Review.

3.

Clopidogrel and modified-release dipyridamole for the prevention of occlusive vascular events (review of Technology Appraisal No. 90): a systematic review and economic analysis.

Greenhalgh J, Bagust A, Boland A, Martin Saborido C, Oyee J, Blundell M, Dundar Y, Dickson R, Proudlove C, Fisher M.

Health Technol Assess. 2011 Sep;15(31):1-178. doi: 10.3310/hta15310. Review.

4.

Combination antiplatelet agents for secondary prevention of ischemic stroke.

Vande Griend JP, Saseen JJ.

Pharmacotherapy. 2008 Oct;28(10):1233-42. doi: 10.1592/phco.28.10.1233. Review.

PMID:
18823219
5.

Antiplatelet therapy in ischemic stroke: variability in clinical trials and its impact on choosing the appropriate therapy.

Biller J.

J Neurol Sci. 2009 Sep 15;284(1-2):1-9. doi: 10.1016/j.jns.2009.04.001. Epub 2009 Apr 19. Review.

PMID:
19380153
6.

Antiplatelet agents for prevention of recurrent ischemic stroke.

Hegge KA.

S D Med. 2009 Jan;62(1):15-7. Review.

PMID:
19245087
7.

Dual or mono antiplatelet therapy for patients with acute ischemic stroke or transient ischemic attack: systematic review and meta-analysis of randomized controlled trials.

Geeganage CM, Diener HC, Algra A, Chen C, Topol EJ, Dengler R, Markus HS, Bath MW, Bath PM; Acute Antiplatelet Stroke Trialists Collaboration.

Stroke. 2012 Apr;43(4):1058-66. doi: 10.1161/STROKEAHA.111.637686. Epub 2012 Jan 26. Review.

8.

The PRoFESS trial: future impact on secondary stroke prevention.

Diener HC.

Expert Rev Neurother. 2007 Sep;7(9):1085-91. Review.

PMID:
17868007
9.

[The value of platelet inhibitors in the secondary prophylaxis of stroke -- a review].

Schellinger PD, Jüttler E, Meyding-Lamadé UK, Schwark C.

Fortschr Neurol Psychiatr. 2004 May;72(5):270-81. Review. German.

PMID:
15136948
10.

Antiplatelet regimens in the long-term secondary prevention of transient ischaemic attack and ischaemic stroke: an updated network meta-analysis.

Niu PP, Guo ZN, Jin H, Xing YQ, Yang Y.

BMJ Open. 2016 Mar 17;6(3):e009013. doi: 10.1136/bmjopen-2015-009013. Review.

11.

Risk-benefit profile of long-term dual- versus single-antiplatelet therapy among patients with ischemic stroke: a systematic review and meta-analysis.

Lee M, Saver JL, Hong KS, Rao NM, Wu YL, Ovbiagele B.

Ann Intern Med. 2013 Oct 1;159(7):463-70. doi: 10.7326/0003-4819-159-7-201310010-00006. Review.

PMID:
24081287
12.
13.

Clinical pharmacokinetics of antiplatelet agents used in the secondary prevention of stroke.

Lenz T, Wilson A.

Clin Pharmacokinet. 2003;42(10):909-20. Review.

PMID:
12885264
14.

Antiplatelet agents and randomized trials.

Diener HC.

Rev Neurol Dis. 2007 Fall;4(4):177-83. Review.

PMID:
18195669
15.

Prevention of secondary stroke and transient ischaemic attack with antiplatelet therapy: the role of the primary care physician [corrected].

Kirshner HS.

Int J Clin Pract. 2007 Oct;61(10):1739-48. Review. Erratum in: Int J Clin Pract. 2007 Nov;61(11):1957.

16.

Review of antiplatelet therapy in secondary prevention of cerebrovascular events: a need for direct comparisons between antiplatelet agents.

Jamieson DG, Parekh A, Ezekowitz MD.

J Cardiovasc Pharmacol Ther. 2005 Sep;10(3):153-61. Review.

PMID:
16211203
18.

Antiplatelet therapy for stroke prevention.

Hankey GJ.

Curr Atheroscler Rep. 2007 Oct;9(4):312-8. Review.

PMID:
18173959
19.

[Antithrombotic therapy after cerebral ischemia].

Schellinger PD, Orberk E, Hacke W.

Fortschr Neurol Psychiatr. 1997 Sep;65(9):425-34. Review. German.

PMID:
9417427
20.

Aspirin plus clopidogrel as secondary prevention after stroke or transient ischemic attack: a systematic review and meta-analysis.

Zhang Q, Wang C, Zheng M, Li Y, Li J, Zhang L, Shang X, Yan C.

Cerebrovasc Dis. 2015;39(1):13-22. doi: 10.1159/000369778. Epub 2014 Dec 24. Review. Erratum in: Cerebrovasc Dis. 2015;39(3-4):249-51.

PMID:
25547900

Supplemental Content

Support Center